For: | Imyanitov E, Kuligina E. Molecular testing for colorectal cancer: Clinical applications. World J Gastrointest Oncol 2021; 13(10): 1288-1301 [PMID: 34721767 DOI: 10.4251/wjgo.v13.i10.1288] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v13/i10/1288.htm |
Number | Citing Articles |
1 |
Aleksandr S. Martianov, Natalia V. Mitiushkina, Anastasia N. Ershova, Darya E. Martynenko, Mikhail G. Bubnov, Priscilla Amankwah, Grigory A. Yanus, Svetlana N. Aleksakhina, Vladislav I. Tiurin, Aigul R. Venina, Aleksandra A. Anuskina, Yuliy A. Gorgul, Anna D. Shestakova, Mikhail A. Maidin, Alexey M. Belyaev, Liliya S. Baboshkina, Aglaya G. Iyevleva, Evgeny N. Imyanitov. KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas. International Journal of Molecular Sciences 2023; 24(5): 4868 doi: 10.3390/ijms24054868
|
2 |
Shreya Beniwal, Paula Lamo, Ajeet Kaushik, Dionisio Lorenzo-Villegas, Yuguang Liu, ArunSundar MohanaSundaram. Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics. Biosensors 2023; 13(10): 926 doi: 10.3390/bios13100926
|
3 |
Ming-Ming Yu, Dan Shi, Qi Li, Jian-Bin Li, Qiang Li, Ri-Sheng Yu. KRAS mutation status between left- and right-sided colorectal cancer: are there any differences in computed tomography?. Japanese Journal of Radiology 2023; 41(1): 83 doi: 10.1007/s11604-022-01326-6
|
4 |
Philip D. Dunne, Mark J. Arends. Molecular pathological classification of colorectal cancer—an update. Virchows Archiv 2024; 484(2): 273 doi: 10.1007/s00428-024-03746-3
|
5 |
Xiao-Ting Liu, Zhi-Yong Kou, Hushan Zhang, Jian Dong, Jian-Hua Zhang, You-Jun Peng, Shu Min Ma, Lei Liang, Xuan-Yu Meng, Yuan Zhou, Jun Yang. Somatic mutation profiling, tumor-infiltrating leukocytes, tertiary lymphoid structures and PD-L1 protein expression in HER2-amplified colorectal cancer. PeerJ 2023; 11: e15261 doi: 10.7717/peerj.15261
|
6 |
Mengjia Qian, Yanxia Zhan, Lili Ji, Hao Chen, Yunfeng Cheng. Expert consensus on standardized management of tumor gene sequencing for cancer patients. Clinical and Translational Discovery 2023; 3(4) doi: 10.1002/ctd2.216
|
7 |
Rimma S. Mulkidjan, Evgeniya S. Saitova, Elena V. Preobrazhenskaya, Karimat A. Asadulaeva, Mikhail G. Bubnov, Ekaterina A. Otradnova, Darya M. Terina, Sofia S. Shulga, Darya E. Martynenko, Maria V. Semina, Evgeniya V. Belogubova, Vladislav I. Tiurin, Priscilla S. Amankwah, Aleksandr S. Martianov, Evgeny N. Imyanitov. ALK, ROS1, RET and NTRK1–3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers. International Journal of Molecular Sciences 2023; 24(17): 13610 doi: 10.3390/ijms241713610
|
8 |
Friederike Wrana, Katharina Dötzer, Martin Prüfer, Jens Werner, Barbara Mayer. High Dual Expression of the Biomarkers CD44v6/α2β1 and CD44v6/PD-L1 Indicate Early Recurrence after Colorectal Hepatic Metastasectomy. Cancers 2022; 14(8): 1939 doi: 10.3390/cancers14081939
|
9 |
Madilyn Heit, Stacey A. Cohen. Contemporary Use of ctDNA for the Colorectal Surgeon. Clinics in Colon and Rectal Surgery 2024; doi: 10.1055/s-0044-1801379
|
10 |
Elena-Roxana Avădănei, Irina-Draga Căruntu, Irina Nucă, Raluca Anca Balan, Ludmila Lozneanu, Simona-Eliza Giusca, Diana Lavinia Pricope, Cristina Gena Dascalu, Cornelia Amalinei. KRAS Mutation Status in Relation to Clinicopathological Characteristics of Romanian Colorectal Cancer Patients. Current Issues in Molecular Biology 2025; 47(2): 120 doi: 10.3390/cimb47020120
|
11 |
Álmos Tilajka, Anita Kurilla, Loretta László, Anna Lovrics, Julianna Novák, Tamás Takács, László Buday, Virag Vas. Predictive value analysis of the interaction network of Tks4 scaffold protein in colon cancer. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1414805
|
12 |
Harshabad Singh, Ashley Kang, Lisa Bloudek, Ling-I Hsu, Maria Corinna Palanca-Wessels, Michael Stecher, Muriel Siadak, Kimmie Ng. Systematic literature review and meta-analysis of HER2 amplification, overexpression, and positivity in colorectal cancer. JNCI Cancer Spectrum 2024; 8(1) doi: 10.1093/jncics/pkad082
|